SkyCell

PharmaLifeScience News

...

Navigating new risks: How China’s Anti-Espionage Law could impact pharmaceutical supply chains

The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential drug ingredients. 

READ MORE
...

Can Ireland sustain its leadership in tech, pharma and engineering?

At least 20pc of Ireland’s 964,000 primary and secondary students will need to study STEM – science, technology, engineering and mathematics – in order sustain the country’s leadership in tech, pharmaceuticals and engineering. 

READ MORE
...

The people-first approach transforming eClinical processes
With the boom in eClinical solutions showing no signs of slowing, adding a “human at the center” perspective can help optimize data management
READ MORE

Aditum Bio and Leads Biolabs join forces in new company to fight autoimmune diseases

How to adapt to choppy waters in biotech ecosystem

Fueling accelerated drug development in autoimmune diseases with a modality-agnostic approach

Scientists Discover a Hidden Ally in the Fight Against Cancer

Kancera announces focus on cardiovascular diseases

Biotech investors, including Third Rock, pump $100M into a startup’s genetic medicine for ALS

FDA grants breakthrough status to J&J’s nipocalimab for SjD treatment

Avid Bioservices to go private in $1.1bn private equity deal

UCD-led EU project aims to revolutionise biomedical research

AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial

Investment surges, hurdles and emerging innovations in neuroscience

Ali Parsa is back in digital health with start-up Quadrivia

Sarepta discontinues development of Duchenne ASO treatment vesleteplirsen

Robert Kennedy Jr’s influence over Trump sparks Big Pharma alarm

UK health data ecosystem 'is hampering research'

Cigna confirms it is not pursuing Humana acquisition

AstraZeneca invests USD 3.5 billion in the United States

Lupin to develop near-zero global warming inhalers

Metsera raises $215M to accelerate obesity drug plans

‘Tremendous potential’: Cell therapy shows promise in treating deadly brain cancer in new trial

Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint
Ellab